Patient-Focused Drug Development Events May Be Giving Way To Small, Private Meetings With FDA

Patient listening sessions, which are easier to schedule, have overtaken traditional patient-focused drug development meetings in terms of volume, although US FDA’s data may be incomplete.

Small meeting
The private, and smaller, patient listening sessions can be scheduled faster than traditional patient-focused drug development meetings. • Source: Shutterstock

Small private meetings with US Food and Drug Administration staff are now more widely used than larger public events to gather first-hand patient information to aid regulatory decisions.

Patient listening sessions (behind-closed-doors gatherings of a small group of patients and advocates to discuss experiences and unmet needs with...

More from R&D

More from Pink Sheet